Company profile
Alchemab Therapeutics Ltd
Alchemab Therapeutics | Harnessing the Power of the Immune System
Alchemab Therapeutics Ltd is a UK company with status active founded in 2019.
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzUyNzM0MzQ2OWFkaXF6a2N4
Published 19 Jun 2026 14:23
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzUyNzM0MTg0NWFkaXF6a2N4
Published 19 Jun 2026 14:20
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzUyNzMzODY5MmFkaXF6a2N4
Published 19 Jun 2026 13:35
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MDA4MjkzMmFkaXF6a2N4
Published 18 Oct 2024 02:11
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNTYzNjU5MGFkaXF6a2N4
Published 16 Sep 2024 08:52
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTUyODE0NmFkaXF6a2N4
Published 12 Sep 2024 16:18
Resolution
ResolutionRESOLUTIONS | Transaction WURBMk1LWDVhZGlxemtjeA | Paper/PDF filed
Published 29 Aug 2024 07:00
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Pre-clinical Development of novel ‘self’-antibodies for disease modification in Huntington’s Disease
1 Dec 2022 to 29 Feb 2024
Alchemab Therapeutics has a new way of approaching drug discovery by focussing on what keeps people well, sometimes against the odds. All of us produce a vast repertoire of different antibodies as part of our usual immune responses to fend off pathogens and to help the body maintain its health status. We believe that some individuals are able to use this ...
Novel protective 'self'-antibodies for disease modification in Huntington’s Disease
1 Mar 2021 to 31 Oct 2022
Alchemab Therapeutics has a new way of approaching drug discovery by focussing on what keeps people well, sometimes against the odds. All of us produce a vast repertoire of different antibodies as part of our usual immune responses to fend off pathogens and to help the body maintain its health status. We believe that some individuals are able to use this ...